Jean-Louis Legoux - Concepedia

Author

Jean-Louis Legoux

Centre hospitalier universitaire d'Orléans ORCID

Also Known As

Christian Platini, J L Legoux, J LEGOUX, J. -L. Legoux, J. Legoux, J.-L. Legoux, J.L. Legoux, Jean-Louis Legoux, Jean‐Louis Legoux, LEGOUX, Jean-Louis

108

Publications

Citations

H-Index

Concepts

All Affiliations

Centre hospitalier universitaire d'Orléans Inserm Assistance Publique – Hôpitaux de Paris Centre Hospitalier Universitaire de Tours Hôpital Cardiologique du Haut-Lévêque

About

Jean-Louis Legoux is an author at Centre hospitalier universitaire d'Orléans specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	803
2	Gastroenterology	5	5	243
3	Immunology	2	2	57
4	Geriatrics	1	1	13
5	Hepatology	1	1	106

Jean-Louis Legoux

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer Thierry Conroy, Pascal Hammel, Mohamed Hebbar, New England Journal of Medicine	2018	2.7K
Sclerotherapy with or without Octreotide for Acute Variceal Bleeding Isabelle Besson, Pierre Ingrand, Bruno Person, New England Journal of Medicine	1995	275
Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 french endoscopy centers Johan Dubuc, Jean-Louis Legoux, María Winnock, Endoscopy	2006	124
Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) Jean‐Pierre Gérard, Thierry André, Frédéric Bibeau, Digestive and Liver Disease Gastrointestinal OncologyMedicineCancer RecurrenceCancer ManagementColorectal Cancer	2017	122
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort Thomas Walter, David Tougeron, Éric Baudin, European Journal of Cancer Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicineNeuroendocrine Disorder	2017	109
Time until definitive quality of life score deterioration as a means of longitudinal analysis for treatment trials in patients with metastatic pancreatic adenocarcinoma Franck Bonnetain, Laëtitia Dahan, E. Maillard, European Journal of Cancer Quality Of LifeSurgical OncologyDefinitive QualityPancreatic CancerLongevity	2010	107
Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma Jean–Louis Jouve, Thierry Lecomte, Olivier Bouché, Journal of Hepatology OncologyHepatologyPravastatin CombinationMedicinePathology	2019	106
Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02) Thomas Aparicio, Sandrine Lavau‐Denès, Jean–Marc Phelip, Annals of Oncology Elderly PatientsGastrointestinal OncologyMedicinePharmacologyClinical Trials	2015	104
Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301) Laëtitia Dahan, Franck Bonnetain, Marc Ychou, Gut	2010	81
Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD‐NADEGE cohort study of 347 patients Thomas Aparicio, Julie Henriques, Sylvain Manfrédi, International Journal of Cancer Surgical OncologyGastrointestinal OncologyMedicineSurgical PathologyGastroenterology	2020	76

Page 1